Welcome to our dedicated page for Neogen SEC filings (Ticker: NEOG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Neogen Corporation (NEOG) SEC filings page provides access to the company’s official regulatory disclosures filed with the U.S. Securities and Exchange Commission. These documents offer detailed insight into Neogen’s operations in food safety, animal safety, and related markets, as well as its governance, compensation practices, and financial condition.
Neogen uses current reports on Form 8-K to disclose material events such as the appointment of a new President and Chief Executive Officer, changes in the Chief Financial Officer role, director retirements and appointments, and the results of shareholder votes at its annual meeting. Filings describe executive compensation arrangements, including base salary, annual bonus targets, long-term equity incentives, and performance share unit programs tied to metrics like revenue growth, adjusted EBITDA margin expansion, and cash flow conversion.
Investors can also review 8-K filings that furnish earnings press releases, which summarize quarterly and annual results, segment performance for Food Safety and Animal Safety, and non-GAAP measures such as adjusted EBITDA. These filings complement the company’s financial statements by providing narrative context and reconciliations.
On Stock Titan, NEOG filings are updated as they are posted to EDGAR, and AI-powered summaries can help explain key elements of lengthy documents, including annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K. Users can quickly identify disclosures related to executive and director changes, incentive plans, shareholder meeting outcomes, and other governance matters.
This page is a resource for understanding how Neogen describes its strategy, risk factors, performance metrics, and capital structure in its own words through formal SEC filings, with tools to make complex regulatory content more accessible.
Jeffrey D. Capello, a director of Neogen Corporation (NEOG), had 2,071 restricted stock units vest and settle on 10/07/2025.
The settlement converted the RSUs into 2,071 shares of common stock at an indicated unit price of $5.63, bringing his total beneficial ownership to 28,700 shares following the transaction.
Insider report: A director of Neogen Corporation (NEOG) had 2,071 restricted stock units vest and be settled for 2,071 shares of common stock on 10/07/2025. The transaction is recorded as a vesting/settlement (code M) with an indicated price of $5.63 per share. After the settlement the reporting person beneficially owned 92,545 shares. The Form 4 was signed on 10/09/2025.
William T. Boehm, a director of Neogen Corp (NEOG), had 2,071 restricted stock units vest and be settled into 2,071 shares of Common Stock on 10/07/2025 at a reported per‑share value of $5.63. After the transaction Mr. Boehm beneficially owns 38,285 shares directly. The Form 4 was signed by an attorney‑in‑fact on 10/09/2025.
Neogen Corp (NEOG) reported transactional and control updates for the quarter ended August 31, 2025. The company recognized a $76,390 gain on the sale of a business, received $121,724 in cash at closing (net of cash divested) and may receive up to $3,500 in contingent earnout consideration tied to 12 months of post‑closing revenue performance. The company made debt actions including $51,500 of principal activity on a Revolving Facility, $45,000 of prepayments on the Term Loan (generating a $393 extinguishment loss) and repurchased $3,500 million of Senior Notes (generating a $41 extinguishment loss). Management is strengthening internal controls, hiring dedicated control personnel, implementing document retention, and providing COSO framework training. The filing notes potential impacts from the Pillar Two global minimum tax rules and a forecasted top‑up tax mechanism, but no material top‑up tax was forecasted for foreign subsidiaries for the quarter.
Neogen Corporation filed a current report to note that it has released financial results for its fiscal 2026 first quarter, which ended on August 31, 2025. The company issued a press release on October 9, 2025 summarizing its operations and financial condition for that quarter, and attached this release as an exhibit to the report. The filing clarifies that the press release is being furnished, rather than filed, under securities laws, which affects how it is treated for certain legal and liability purposes.
Neogen Corporation reported that its Chief Financial Officer and Chief Operating Officer, David Naemura, has informed the company of his intention to resign to pursue other opportunities. The company stated that his decision is not related to any disagreement over operations, financial statements, accounting policies, or internal controls. He will continue in his current roles until a departure date expected between the filing of Neogen’s October Form 10-Q and the end of the calendar year, helping ensure continuity.
The board’s Compensation and Talent Management Committee determined it is in the company’s and shareholders’ best interests for Naemura to assist with onboarding a new Chief Financial Officer. Under a transition agreement, if he remains employed through December 31, 2025, he will be eligible, in addition to his base pay, to receive 50% of his annual target cash bonus under Neogen’s annual incentive plan. Neogen also issued a press release announcing his resignation.
The filing describes how certain executive Performance Stock Units (PSUs) will be settled after the end of the Performance Period. An independent committee will compare the Companys actual performance to the pre-established metrics and apply an rTSR multiplier to determine how many PSUs, if any, are earned. Any earned PSUs will be converted into shares of the Companys common stock and issued to the named executive officer as soon as practicable, and those shares will be fully vested upon issuance. Until settlement, the PSUs do not give the executives any ownership interest or shareholder rights.
Neogen Corp (NEOG) officer John Edward Adent reported the vesting and settlement of restricted stock units into common stock on August 18, 2025. The filing shows 35,736 RSUs vested and were settled for 35,736 shares at an effective price of $5.43 per share, increasing his direct holdings to 307,012 shares following the transaction. The Form 4 was signed by an attorney-in-fact on August 20, 2025.
Neogen Corp (NEOG) insider activity: Douglas Edward Jones, the Chief Operating Officer and a director, reported transactions on 08/18/2025 where 14,294 restricted stock units vested and were settled into 14,294 shares at an implied price of $5.43 per share, increasing his beneficial ownership to 86,007 shares. The filing also shows a separate disposition of 4,160 shares at $5.43, leaving 81,847 shares after that sale. The Form 4 was signed by an attorney-in-fact on 08/20/2025. The filer notes each RSU is the economic equivalent of one common share and that the RSUs vested and were settled on 08/18/2025.
Neogen Corp (NEOG) Form 4 summary: Chief Financial Officer David H. Naemura reported vesting and settlement of 14,294 restricted stock units on 08/18/2025 at an indicated price of $5.43 per share, resulting in acquisition of 14,294 shares. The filing also shows a contemporaneous disposition of 5,947 shares at $5.43, leaving the reporting person with 69,781 shares after the transactions. The form was signed by an attorney-in-fact on 08/20/2025. This filing documents an insider equity vesting event and partial sale of shares.